Peter Thygesen

2.5k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Peter Thygesen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, Peter Thygesen has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Immunology. Recurrent topics in Peter Thygesen's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Advanced Condensed Matter Physics (5 papers) and Magnetic and transport properties of perovskites and related materials (4 papers). Peter Thygesen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Advanced Condensed Matter Physics (5 papers) and Magnetic and transport properties of perovskites and related materials (4 papers). Peter Thygesen collaborates with scholars based in Denmark, United Kingdom and United States. Peter Thygesen's co-authors include Søren Thor Larsen, Otto Melchior Poulsen, Dorte X. Gram, J. H. McGuire, Sanne Møller Knudsen, Lauge Schäffer, Dorte B. Steensgaard, Thomas Kruse, F. S. Nielsen and Kjeld Madsen and has published in prestigious journals such as Journal of the American Chemical Society, Physical Review Letters and The Journal of Immunology.

In The Last Decade

Peter Thygesen

52 papers receiving 1.8k citations

Hit Papers

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Thygesen Denmark 21 733 501 289 234 228 54 1.9k
Michel Sève France 23 876 1.2× 169 0.3× 176 0.6× 438 1.9× 286 1.3× 98 2.3k
Jaime Mas‐Oliva Mexico 24 968 1.3× 174 0.3× 235 0.8× 34 0.1× 328 1.4× 106 1.9k
Dante G. Scarpelli United States 26 770 1.1× 179 0.4× 78 0.3× 94 0.4× 695 3.0× 81 2.3k
Sushanta K. Banerjee United States 36 1.7k 2.4× 194 0.4× 324 1.1× 23 0.1× 212 0.9× 98 3.1k
Guimin Wang China 24 434 0.6× 184 0.4× 73 0.3× 137 0.6× 78 0.3× 84 1.7k
Hanumanthappa Krishnamurthy India 22 713 1.0× 171 0.3× 232 0.8× 60 0.3× 51 0.2× 31 2.2k
Tracy Robson United Kingdom 40 1.8k 2.5× 65 0.1× 518 1.8× 70 0.3× 176 0.8× 116 3.8k
Lucas L. Colombo Argentina 23 810 1.1× 56 0.1× 296 1.0× 40 0.2× 102 0.4× 76 2.0k
Jung‐Mo Ahn United States 26 1.1k 1.6× 449 0.9× 62 0.2× 16 0.1× 326 1.4× 63 2.1k
Vladimir V. Didenko United States 19 1.2k 1.6× 53 0.1× 258 0.9× 81 0.3× 146 0.6× 54 2.2k

Countries citing papers authored by Peter Thygesen

Since Specialization
Citations

This map shows the geographic impact of Peter Thygesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Thygesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Thygesen more than expected).

Fields of papers citing papers by Peter Thygesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Thygesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Thygesen. The network helps show where Peter Thygesen may publish in the future.

Co-authorship network of co-authors of Peter Thygesen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Thygesen. A scholar is included among the top collaborators of Peter Thygesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Thygesen. Peter Thygesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thygesen, Peter. (2024). Regulation of genome edited organisms in Australia. Transgenic Research. 33(6). 545–550. 4 indexed citations
2.
Thygesen, Peter, Karin Weldingh, Esther Bloem, et al.. (2022). CTLA4‐Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA rats. Haemophilia. 28(4). 568–577. 2 indexed citations
3.
Almholt, Kasper, Jesper Pass, Gustav Røder, et al.. (2020). Identification and preclinical development of an anti-proteolytic uPA antibody for rheumatoid arthritis. Journal of Molecular Medicine. 98(4). 585–593. 1 indexed citations
4.
Hill, Joshua A., Claire A. Murray, Chiu C. Tang, et al.. (2019). Inorganic co-crystal formation and thermal disproportionation in a dicyanometallate ‘superperovskite’. Chemical Communications. 55(38). 5439–5442. 2 indexed citations
5.
Thygesen, Peter. (2019). Clarifying the regulation of genome editing in Australia: situation for genetically modified organisms. Transgenic Research. 28(S2). 151–159. 36 indexed citations
6.
Almholt, Kasper, Josephine B. Hebsgaard, Anneline Nansen, et al.. (2017). Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models. The Journal of Immunology. 200(3). 957–965. 19 indexed citations
7.
Paddison, Joseph A. M., Peter Thygesen, Andrew L. Goodwin, et al.. (2017). Orbital Dimer Model for Spin-Glass State in Y$_2$Mo$_2$O$_7$. Bulletin of the American Physical Society. 2017. 2 indexed citations
8.
Thygesen, Peter, Henrik Sune Andersen, Carsten Behrens, et al.. (2017). Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone. Growth Hormone & IGF Research. 35. 8–16. 26 indexed citations
9.
Thygesen, Peter, et al.. (2016). The kidneys play a central role in the clearance of rhGH in rats. European Journal of Pharmaceutical Sciences. 86. 29–33. 6 indexed citations
10.
Thygesen, Peter, Panos Macheras, & Achiel Van Peer. (2009). Physiologically-Based PK/PD Modelling of Therapeutic Macromolecules. Pharmaceutical Research. 26(12). 2543–2550. 25 indexed citations
11.
Davis, Ian D., Birte K. Skrumsager, Jonathan Cebon, et al.. (2007). An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma. Clinical Cancer Research. 13(12). 3630–3636. 132 indexed citations
12.
Kjellev, Stine, Else Marie Vestergaard, Ebba Nexø, et al.. (2007). Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents. Peptides. 28(6). 1197–1206. 27 indexed citations
13.
Frøkjær, Sven, et al.. (2006). 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart. International Journal of Pharmaceutics. 330(1-2). 114–120. 4 indexed citations
14.
Larsen, Søren Thor, Gunnar Damgaard Nielsen, & Peter Thygesen. (2002). Investigation of the adjuvant effect of polyethylene glycol (PEG) 400 in BALB/c mice. International Journal of Pharmaceutics. 231(1). 51–55. 20 indexed citations
15.
Larsen, Søren Thor, et al.. (2002). Investigation of the adjuvant and immuno-suppressive effects of benzyl butyl phthalate, phthalic acid and benzyl alcohol in a murine injection model. Food and Chemical Toxicology. 41(3). 439–446. 40 indexed citations
16.
Larsen, Søren Thor, et al.. (2001). Adjuvant and immuno-suppressive effect of six monophthalates in a subcutaneous injection model with BALB/c mice. Toxicology. 169(1). 37–51. 73 indexed citations
19.
Sim, Edith, Lesley A. Stanley, Angela Risch, & Peter Thygesen. (1995). Xenogenetics in multifactorial disease susceptibility. Trends in Genetics. 11(12). 509–512. 9 indexed citations
20.
Thygesen, Peter, et al.. (1990). Identification of the mononuclear cell infiltrate in the superior cervical ganglion of athymic nude and euthymic rats after guanethidine-induced sympathectomy. International Journal of Immunopharmacology. 12(3). 327–330. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026